Growth inhibition of the lower trypanosomatids Crithidia fasciculata and a Leptomonas from a hemipteron by several established trypanocides and leishmanicides were compared in four complex and one defined media. The Leptomonas was more susceptible than C. fasciculata in all media, especially to phenanthridines (ethidium, prothidium, isometamidium} and diamidines (pentamidine, diminazene diaceturate [Berenil] , hydroxystilbamidine, stilbamidine); concentrations of these drugs required for 50% inhibition of the Leptomonas were <5 ug/ml. In contrast, C. fasciculata was uninhibited by <20 gg of diamidines per ml and was three-to sixfold less susceptible than the Leptomonas to isometamidium and prothidium. Both trypanosomatids were susceptible to nucleoside antibiotics, e.g., nucleocidin. Neither was inhibited by suramin, melarsen, melarsen oxide, or tryparsamide. The Leptomonas was more susceptible to standard trypanocides than five other insect trypanosomatids in a complex medium; it was the only one inhibited by <20 gg of stilbamidine and hydroxystilbamidine per ml.
No novel drugs have been introduced in the past 25 years against trypanosomiasis and leishmaniasis (5), yet the incidence of African trypanosomiasis is not declining (8) . Drug resistance is spreading in human and animal infections (12, 13) and is likewise increasing in leishmanial infections (13) . The drugs available for use against the various leishmaniases are occasionally quite toxic at therapeutic dosages (16) . Treatment of Chagas' disease with the one drug available (nifurtimox) is protracted and poorly tolerated by many adults (20) ; naturally resistant strains are reported from Chile (15) .
Present means for the in vivo evaluation of candidate drugs depends upon the existence of lead compounds of known structure or upon recognition of high-activity natural products. Such tests are costly since they require much material, animals, and labor. In vitro tests with the pathogens require culture media generally containing unheated blood, a source of contaminants, especially mycoplasmas (6 Na, DL-a,,6-glycerophosphate (Sigma Chemical Co., 75% ,-isomer), 7.5; hemin in milligrams (added as in Table 1 ) and Quadrol to pH 7.4. TBM also grew 11 other Crithidia isolates, several Herpetomonas spp., and Trypanosoma mega.
Growth-inhibition tests. Test media were in 50-ml microfernbach flasks (Bellco) containing 10 ml final volume. Thermostable solutions and media were autoclaved for 20 min at 121 C. Growth-curves were run in triplicate and included pH controls for the "no drug" flasks and flasks with the highest drug concentration. Flasks were inoculated with 1 drop (0.04 to 0.06 ml) of 72-h log-phase cultures grown in screwcapped test tubes (20 by 125 mm); flasks in any one ANTiDICROB. AG. CHEMOTHE. were put in Pyrex utility trays, taped after inoculation to inverted trays. Incubation temperatures were as for stock cultures. Incubation of assays varied with organism and medium: Leptomonas was incubated 6 days in CS, MM, and HY, 5 days in TBM, and 4 days in MM; C. fasciculata was incubated 3 days in CS and MM and 4 days in TBM; L. pemoai and B. culicis were incubated 5 days in TBM; C. oncopelti and C. acanthocephali were incubated 4 days in TBM.
Drug solutions were prepared just before use. The drug (20 mg ) was added to 20 ml of sterile water, and aseptic serial dilutions were made. The volume of drug additions was not more than 2.5 ml. Most drugs were water soluble except for agaricin, 4-cumylphenol, and melarsen oxide; these were solubilized with several drops of 5 M KOH. Cordycepin stock solutions had to be filter-sterilized (Kreuger A-400 H.A.K.-1 pad, prewashed) because of initially high contamination rates.
Microscopic checks for contamination were made in all assays; random samples from flasks were cultured on brain heart infusion agar (BBL) and thioglycolate broth (Difco) both at 30 and 38 C. Contamination was < 
RESULTS
The CS, MM, and HY media were used initially in this study. CS medium was used for comparative studies on the Leptomonas and C. fasciculata. The MM medium permitted the lowest 1]60 for the Leptomonas. Large quantities (3.5 g [wet weight] per liter) of "no drug" cells as well as drug-inhibited cells were obtained in HY medium for biochemical studies on the Leptomonas (to be reported elsewhere). Except for C. oncopelti, all flagellates used grew in the defined medium, but their absorbances were <0.50.
The drugs chosen are in practical use as trypanocides or leishmanicides or else are progenitors of useful drugs. The antimalarials primaquine, quinacrine, and chloroquine served as controls of specificity. Agaricin and 4-cumylphenol, experimental antitumor agents, are potent a-glycerophosphate dehydrogenase inhibitors (1). Crystal violet is commonly added to banked blood in South America to kill T. cruzi; the dye so used has negligible toxicity (3). Table 2 compares the Leptomonas sp. and C. fasciculata in complex media; most trypanocides tested, aside from the organo-arsenicals and suramin, gave ID,0 >50 gg/ml for the Leptomonas. C. fasciculata grown in CS medium was susceptible to several drugs, yet was relatively refractory to the diamidines. The Leptomonas was most susceptible in the MM medium, particularly to the diamidines, nucleoside antibiotics, Antrycide, and the acridines.
Responses of C. fasciculata and the Leptomonas to some practical antityrpanosomatid agents were compared in the defined medium ( Table 3 ). The observed susceptibilities were similar to those observed with the CS medium: unsusceptibility of C. fasiculkta to the diamidines and low ID,0 for the Leptomonas with ethidium, prothidium, crystal violet, and acriflavine. Interestingly, C. fasciculata was unsusceptible to Antrycide in the defined medium. Leptomonas was -fivefold less susceptible to hydroxystilbamidine in the defined medium than in CS or MM media.
Susceptibilities of other insect trypanosomatids to antitrypanosomatid agents were tested on several Crithidia spp., L. pessoai, and B. culicis (Table 4 ). The Leptomonas.was generally more susceptible than the other trypanosomatids grown on TBM medium. Antrycide was less VOL. 6, 1974 on November 2, 2017 by guest http://aac.asm.org/ Downloaded from ANTIMICROB. AG. CHEMOTHER. and melarsen here were used as controls, also suramin, whose mode of metabolic activation and trypanocidal action remain unknown (2) . The disparate chemotherapeutic patterns in trypanosomatidae argues that, correspondingly, additional lower trypanosomatids should be investigated. Hardy lower trypanosomatids are useful for mode-of-action studies. Crithidia systems were used to study subcellular effects of pentamidine and its uptake (10, 19) , and Newton (11) used C. oncopelti to study the action of Antrycide. Extension of such studies to the Leptomonas now seems warranted since it is appreciably more susceptible than those Crithidia isolates tested.
Another advantage of in vitro procedures is the ease of distinguishing between novel and known agents by comparing wild-type and induced resistant strains of an appropriately susceptible organism. This "finger-printing" technique now finds use in screening for novel antitumor agents as well as antimicrobial antibiotics (14) . The ease of preparation of drugresistant Leptomonas clones indicate that it may be useful for this purpose.
